Viewing Study NCT05748834


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 7:26 AM
Study NCT ID: NCT05748834
Status: RECRUITING
Last Update Posted: 2025-01-31
First Post: 2023-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Sponsor: SCRI Development Innovations, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module